Skip to content

Clinical trials

Completed Phase 4 Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 4 Status: Completed Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20062
20073
20085
20094
20101
20113
20121
20131
20143
20151
20161
20174
20183
20197
20201
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Hoffmann-La Roche6
Radboud University Medical Center3
Boehringer Ingelheim2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Sun Yat-sen University2
Taipei Veterans General Hospital, Taiwan2
Amgen1
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung46
Lung Neoplasms11
Stomach Neoplasms4
Carcinoma3
Carcinoma, Renal Cell3
Esophageal Neoplasms3
Kidney Neoplasms3
Small Cell Lung Carcinoma3
Uterine Cervical Neoplasms3
Carcinoma, Hepatocellular2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.